ELIN.BO(ELIN.BO)
ELIN.BO
No analyst ratings available
No analyst price targets available for ELIN.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E |
|---|---|
| Revenue Avg | $15.51B |
| Low | $15.51B |
| High | $15.51B |
| EBITDA Avg | $909M |
| Low | $909M |
| High | $909M |
| EBIT Avg | $625M |
| Low | $625M |
| High | $625M |
| Net Income Avg | $487M |
| Low | $487M |
| High | $487M |
| EPS Avg | $10.00 |
| Low | $10.00 |
| High | $10.00 |
| Analysts (Rev / EPS) | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.54B | $2.54B | $2.73B | $2.53B | $3.06B | $2.98B | $3.10B | $3.11B |
| Low | $2.54B | $2.54B | $2.73B | $2.53B | $3.06B | $2.98B | $3.10B | $3.11B |
| High | $2.54B | $2.54B | $2.73B | $2.53B | $3.06B | $2.98B | $3.10B | $3.11B |
| EBITDA Avg | $149M | $149M | $160M | $148M | $179M | $175M | $182M | $182M |
| Low | $149M | $149M | $160M | $148M | $179M | $175M | $182M | $182M |
| High | $149M | $149M | $160M | $148M | $179M | $175M | $182M | $182M |
| EBIT Avg | $102M | $102M | $110M | $102M | $123M | $120M | $125M | $125M |
| Low | $102M | $102M | $110M | $102M | $123M | $120M | $125M | $125M |
| High | $102M | $102M | $110M | $102M | $123M | $120M | $125M | $125M |
| Net Income Avg | $39M | $39M | $39M | — | — | — | $49M | $49M |
| Low | $39M | $39M | $39M | — | — | — | $49M | $49M |
| High | $39M | $39M | $39M | — | — | — | $49M | $49M |
| EPS Avg | $0.80 | $0.80 | $0.80 | — | — | — | $1.00 | $1.00 |
| Low | $0.80 | $0.80 | $0.80 | — | — | — | $1.00 | $1.00 |
| High | $0.80 | $0.80 | $0.80 | — | — | — | $1.00 | $1.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / 1 | 1 / 1 |